Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Replicel Life Sciences Inc V.RP

Alternate Symbol(s):  REPCF

RepliCel Life Sciences Inc. is a Canada-based regenerative medicine company. The Company is focused on developing cell therapies for aesthetic and orthopedic conditions, including aging/sun-damaged skin, pattern baldness, and chronic tendon degeneration. The Company’s cell therapy product pipeline is comprised of RCT-01 for tendon repair, RCS-01 for skin rejuvenation, and RCH-01 for hair... see more

TSXV:RP - Post Discussion

Replicel Life Sciences Inc > Wow That Was Exciting
View:
Post by Ingiboy on Jan 26, 2021 11:39am

Wow That Was Exciting

One day later and we are back to this.  No volume, no interest and stock dumping.

One thing that confounds me about this management team is their misread of the market.  Making references to Servona and using it as a model of how the market will react to the news.
Ho hum was the reacton.  Why?  It's simple.  WTF is happening with the Dermal Injector ?
It is all well and good announcing this partnership with Mainpointe but what the market wants to know:
When will the Dermal Injector test units be ready to go ?
Who will be doing the testing ?
How long will the test cycle be ?
Will they simultaneously seek FDA and CE Mark approval ?
When do they estimate the device will be ready to market ? 

These questions could have been answered yesterday while "the iron was hot" but no it will be sometime in early February. Instead of the share price continuing to go up we get what we see today.
Comment by MetzGER on Jan 26, 2021 12:04pm
Ingiboy i am sorry to say that But you Are extremes negative. Last week we were Wondering if the MainPointe Deal fail and we loose our money. now we get an huge Update about the financial Situation of Replicel with These Investment. at this Point we Can Be Happy that Replicel has the cash to move on - this Wasnt Safe as the Pandemic hit in!!! now we only have One week to Wait for Corporate ...more  
Comment by BellEnd on Jan 26, 2021 12:49pm
This post has been removed in accordance with Community Policy
Comment by Ingiboy on Jan 26, 2021 5:36pm
"we know that we will see this dermal injector for market approval[/quote]" The question is when !!! Oh Metzger you are flip/flopping again.  At one point you want to kill someone and then you are the LB defender.  I am simply saying yes we are getting an update next week but this week would have been more effective.  Replicel must read these blogs because all of a sudden ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities